Abstract
In the United States, the two facilities for biological weapons research and production were converted between 1969 and 1972. Between the time that the Biological and Toxins Weapon Convention (BTWC) was signed and came into force-1972 to 1975--and the present time, some six to ten countries have initiated or maintained national BW R&D programs with various degrees of offensive character. None of these, however, appear to be discontinuing their programs at the present time of their own volition or under the pressure of international attention to their divergence from the BTWC. There is, therefore, no current attention being paid to questions dealing with the facilitation of conversion in these other states, Iran or Iraq for example. For the past half dozen years or a bit more, the overwhelming practical issue in the area of the conversion of former BW R&D facilities has been the BW R&D institutes of the former USSR. The examination of BW R&D conversion in this paper will therefore be built almost entirely around this particular current and continuing problem. It is also written entirely from the viewpoint of arms control; that is, economic or marketing issues are not its primary concerns, although these are among the most obvious “limitations” which will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Leitenberg,M. (1994) The Conversion of Biological Warfare Research and Development Facilities to Peaceful Uses, in E. Geissler and J.P. Woodall (eds.), Control of Dual Threat Agents: The Vaccines for Peace Programme, Stockholm International Peace Research Institute and Oxford University Press,. 77–105, and Leitenberg, M. (1996) Biological Weapons Arms Control, PRAC Paper no. 16, Center for International and Security Studies,University of Maryland,Rimmington,A. (1996) From Military to Industrial Complex?, Contemporary Security Policy, 17, 80–112.;Caudle,L.C. (1997), The Biological Warfare Threat in F.R. Sidell et al. (eds.)Medical Aspects of Chemical and Biological Warfare, Washigton, DC, Office of the Surgeon General, 454–455.
Yankulin, V. (1997), Plague Syndrome, or the Purgatory of One of the Creators of Bacteriological Warfare, Izvestiya, October 15,.
In November 1996, Dr. Genady Lepeshkin, the director of the National Center for Biotechnology in Kazakstan, indicated that there were nine biotechnology institutes (in Kazakstan), all of which had been “part of the defense complex.” Apparently only one of these, Stepnogorsk, had previously been identified. It appears that one other of these was part of the Biopreparat organization; the remaining seven were under the authority of other Soviet ministries and agencies.
. Zilinskas, R.A.,(1997) The Other Biological Weapons Worry, New York Times, November 28.
Stone,R., (1997) An Antidote to Bioproliferation, Science, 278, p. 1222. Stone however adds that “…an estimated 150 to 200 scientists still work on biological defense related projects at four centers”, which seems to remove any credibility to his estimates. If that were the case, 9,800 researchers would already have been “converted” in one way or another.
. Devroy, A and Smith,R.J.(1992), U.S., Russia Pledge New Partnership, Washington Post, February 2.
Dahlburg, J. T. (1992), Russia Admits Violating Biological Warfare Pact, Los Angeles Times, September 15, and Gordon, M.R. (1992). Russia and West Reach Accord on Monitoring Germ Weapon Ban, Washington Post, September 15.
Leitenberg, M. (1994) The Conversion of Biological Warfare,“ op. cit., and Leitenberg,M.(1994) Biological Weapons Arms Control, (note 1)
For overall surveys, see:
Leonid Kosals, “Military R&D Institutes in the Context of Demilitarization in Russia,” WP-94–002, International Institute for Applied Systems Analysis, Laxenburg, Austria, January 1994.
Ksenia Gonchar, Research and Development (R&D) Conversion in Russia, Report no. 10, Bonn International Center for Conversion, Bonn, Germany, May 1997.
Deni, J. R. and Harrington A. M. (1995) Beyond Brain Drain: The Future of Nonproliferation Through Science Cooperation’ Programs, Conference Paper, March C30–31 Center for International and Security Studies,University ofMaryland, quoting FRIS-SOV-93–067, April 9, 1993, p. 39, and Izvestia, April 30, 1993,p. 15, in FRIS-SOV-93–085, p. 40.
Vergano, D., (1997) Rough Times in Russia: Post-Soviet Science Faces a New Crisis, Science News, May 10.
Zilinskas,R. personal communication, October 1997.
(USSR Science: Novosti Press Agency, 1973) published the following data for the USSR:
1940: 2,359 research centers (colleges and universities included), including 786 research institutes and their local branches;
1960: 4,196 scientific centers, with a research staff of 354,200;
by the end of 1970: 4,985, including 2,458 research centers and their branches, and 927,700 (research staff);
1973: over 5,300 research establishments and one million researchers.
Öhrner, N. et al., (1996) Some Views on Russian Biotechnology in Academic Institutions, State Research Centres, and Industry,Report from IVA ‘s Biotechnology Delegation to Moscow and Obolensk, 11/16–22/96. It should be noted that there is no external verification of these estimates.
Netesov, S. (1994) The Scientific and Production Association Vector: the current situation“ in: E. Geissler and Jack P. Woodall (eds.), p.133–138, notel
Deni and Harrington, 1995, op. cit., p. 7.
Current and Projected National Security Threats to the United States and its Interests Abroad, Hearing before the Select Committee on Intelligence, United States Senate, 104th Congress, 2nd Session, February 22, 1996, Washington, DC: US Govt. Printing Office, 1996, p. 198.
There have been suggestions that Iran, Libya and Syria may have obtained aid for their BW programs from the former USSR. Most of the indications concern Iran more recently, in the post-1992 years. There are also indications that the USSR supplied some assistance to Iraq’s BW program before 1990, as did a sizable number of West European countries. See M. Leitenberg, Biological Weapons Arms Control, op. cit.
International Science Foundation, Annual Report 1995, and 1994 Annual Report Supplement, New York, New York.
Deni and Harrington, op. cit., p. 17.
Zilinskas,R. (1997) personal communication.
Leitenberg, M. (1994) The Conversion of Biological Warfare Research and Development Facilities to Peaceful Uses in E. Geissler and J.P. Woodall (eds.) Vol. 15 SIPRI Chemical and Biological Warfare Studies,Oxford University Press, pp. 77–108. It is important to indicate that this study of the dismantling of Fort Detrick and Pine Bluff was originally prepared in 1984 for a United Nations Secretary General’s study on Military Research and Development, and together with a second detailed study prepared by a Fort Detrick staff member, both became directly available to the Soviet government. This is of importance because Soviet officials claimed that they did not believe that the US had dismantled the two offensive portions of its program.
Williams, D.(1998) Russia Falls Short on Promise to Pay Back Wages, Washington Post, January 8.
Hedén,C.G.(1967) Microbiology in World Affairs“, Impact (UNESCO), 17, 187–208. See also: The Resolution of the Second International Conference on Global Impacts of Applied Microbiology, Addis Ababa, November 1967.
Hedén C.G. and Sinyak,K.(1979) The Fight Against Infectious Diseases: A Role for Applied Microbiology in Military Redeployment, SIPRI,Stockholm International Peace Research Institute
Greenberg, D.A. (1998) A Pittance to Fight Malaria, Washington Post,January 4. Williams, N. (1997) Tropical Diseases: Drug Companies to Collaborate, Science 278, 1704
Hoffman, St., Briefing on United States Deparetment of Defense Malaria Research Programs. naval Medical Research Institute, Malaria Program, May 14, 1996. The irony is that the total US government budget for malaria research is on th order of $ 25 million per year, with malaria a major medical concern for US military forces, while the US Congress mandates that the US Army spend $ 135 million per year on breast cancer research, which should not be considered within the purview of military medical concerns at all.
Infectious Disease - A Global Health Threat; Report of the National Science and Technology Council, Washington, DC, September 1995. See also: Anne E. Platt, Infecting Ourselves: How Environmental and Social Disruptions Trigger Disease, World Watch Paper No. 129, April 1996, Washington DC.
Hydén,C.G. (1992) The 1991 Persian Gulf War: Implications for Biological Arms Control in Zilinskas,R. (ed.) The Microbiologist and Biological Defense Research: Ethics, politics, and International Security, Annals of the New York Academy of Siences, Vol. 666, 1–8
Stone, R. (1997) Russia: An Antidote to Bioproliferation, Science, 278,p. 1222.
Pamela C. Ronald, “Making Rice Disease-Resistant”, Scientific American, 277:5 (November 1997), pp. 100–105.
Gibbs, W.W. (1997) Biotechnology: Human Antibodies Produced by Field Crops Enter Clinical Trials, Scientific American, 277, 44.
Sawyer, K. (1997) With DNA, Simple Cells Perform Acrobatic Feats of Computation“, Washington Post, December 15, Tauber,G.(1997) Salvation in a Snippet of DNA? Science 278,1711–1714, and Ebola Gene Vaccine is promising in Animals, New York Times, December 30, 1997.
Leitenberg, M. (194) The Conversion of Biological Warfare Research and Development Facilities to Peaceful Uses,“,note 1
Feshbach M. and Friendly, A.,Jr., (1992) Ecocide in the USSR: Health and Nature Under Siege, Bloomington Indiana: Basic Books 1992; see also Shapiro, M. (1992) Ex-Soviet Empire the New `Sick Man of Europe’, Washington Post, October 3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Leitenberg, M. (1998). The Possibilities and Limitations of Biological Weapons Conversion. In: Geissler, E., Gazsó, L., Buder, E. (eds) Conversion of Former BTW Facilities. NATO Science Series, vol 21. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5306-5_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-5306-5_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-5250-1
Online ISBN: 978-94-011-5306-5
eBook Packages: Springer Book Archive